UA101951U - PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF COOL - Google Patents

PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF COOL

Info

Publication number
UA101951U
UA101951U UAU201503202U UAU201503202U UA101951U UA 101951 U UA101951 U UA 101951U UA U201503202 U UAU201503202 U UA U201503202U UA U201503202 U UAU201503202 U UA U201503202U UA 101951 U UA101951 U UA 101951U
Authority
UA
Ukraine
Prior art keywords
pharmaceutical composition
cool
prevention
treatment
excipients
Prior art date
Application number
UAU201503202U
Other languages
Russian (ru)
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to UAU201503202U priority Critical patent/UA101951U/en
Publication of UA101951U publication Critical patent/UA101951U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Фармацевтична композиція для лікування і профілактики застуди містить парацетамол і допоміжні речовини. Додатково містить левоцетиризину дигідрохлорид.The pharmaceutical composition for treating and preventing colds contains paracetamol and excipients. Additionally contains levocetirizine dihydrochloride.

UAU201503202U 2015-04-06 2015-04-06 PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF COOL UA101951U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201503202U UA101951U (en) 2015-04-06 2015-04-06 PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF COOL

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201503202U UA101951U (en) 2015-04-06 2015-04-06 PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF COOL

Publications (1)

Publication Number Publication Date
UA101951U true UA101951U (en) 2015-10-12

Family

ID=54773321

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201503202U UA101951U (en) 2015-04-06 2015-04-06 PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF COOL

Country Status (1)

Country Link
UA (1) UA101951U (en)

Similar Documents

Publication Publication Date Title
CO2019008487A2 (en) Quinazoline Compound
CY1123810T1 (en) TRIFLUOROMETHYL SUBSTITUTED PYRAZOLES AS KALLIKREIN INHIBITORS IN HUMAN PLASMA
PH12019501097A1 (en) Magl inhibitors
MX2019000200A (en) Pyrimidine-based antiproliferative agents.
PH12019501102A1 (en) Magl inhibitors
EA201691872A1 (en) HETEROCYCLIC COMPOUNDS FOR APPLICATION IN THE TREATMENT OF PI3K-GAMMA-MEDIATED DISORDERS
MX2017011997A (en) Piperazine carbamates and methods of making and using same.
IL258854A (en) Compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer
MX2016012574A (en) Substituted heteroaryl compounds and methods of use.
PH12020551934A1 (en) Magl inhibitors
CL2015002897A1 (en) Bace1 inhibitors
PH12016500140A1 (en) Heterobicycloaryl rorc2 inhibitors and methods of use thereof
PH12018502154A1 (en) Methods of treating ocular conditions
CY1119532T1 (en) (S) -PYRILDOL AND THE PHARMACEUTALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
CY1124907T1 (en) KALLIKREIN INHIBITORS IN HUMAN PLASMA
EA201792571A1 (en) THERAPEUTIC APPLICATION OF L-4-CHLOROKINURENIN
CY1119522T1 (en) (R) - PILINDOL AND THE PHARMACEUTICALALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
MX2017008879A (en) Pharmaceutical composition for the treatment of mycosis.
UA101951U (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF COOL
UA101950U (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF COOL
TR201722950A2 (en) New pharmaceutical compositions in the treatment of COPD.
EA201890122A1 (en) APPLICATION OF 2- (5S-METHIL-2-OXO-4R-PHENILPYRROLIDIN-1-IL) ACETAMIDE IN THE TREATMENT OF SHIPPERS
SG10201903630UA (en) Iminosugars useful for the treatment of viral diseases
CL2019001046A1 (en) Combination therapy that includes an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancer. (divisional application 201601131)
DK3508202T3 (en) THERAPEUTIC AGENT FOR AMYOTROPHIC LATERAL SCLEROSIS AND COMPOSITION FOR TREATMENT